Hollander David
CIK 0001793796
Chief R&D OfficerDirector
Filings
8
Latest Apr 2, 2025
Issuers covered
3
Showing
8 of 8
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Hollander David. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Hollander David has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KPRX | Kiora Pharmaceuticals Inc | 5 | Apr 2, 2025 |
| RVNC | Revance Therapeutics, Inc. | 2 | Feb 6, 2025 |
| AERI | Aerie Pharmaceuticals Inc | 1 | Feb 8, 2022 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|